help button home button Am J Pathol PCR Enhanced. PCRboost from Biomatrica
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hart, M. N.
Right arrow Articles by Wisniewski, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hart, M. N.
Right arrow Articles by Wisniewski, H. M.

American Journal of Pathology, Vol 132, 167-172, Copyright © 1988 by American Society for Investigative Pathology


REGULAR ARTICLES

beta-amyloid protein of Alzheimer's disease is found in cerebral and spinal cord vascular malformations

MN Hart, P Merz, J Bennett-Gray, AH Menezes, JA Goeken, RL Schelper and HM Wisniewski
Department of Pathology, University of Iowa College of Medicine, Iowa City 52242.

Congo/Red deposition with birefringence to polarized light was demonstrated focally in cerebrovascular malformations removed surgically from 4 older patients (ages 85, 74, 74, and 63), and in a spinal cord vascular malformation in a 76-year-old patient. Lesser degrees of Congophilic change were observed in cerebrovascular malformations screened from 4 of 10 patients between the ages of 30 and 59. No Congophilic change was seen in 10 cerebrovascular malformations removed from patients under 30 years of age. Congophilic areas in all cases decorated with W-2 and 85/45 polyclonal antibodies raised to peptide sequences of cerebrovascular beta-amyloid and beta-amyloid of senile plaques from patients with Alzheimer's disease. Thus, the amyloid in these vascular malformations is immunologically related to beta-amyloid protein. This finding provides another indication that vascular beta-amyloid deposition is not specific for Alzheimer's disease and suggests that an existing abnormality of vessels may be a predisposing factor.


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
J. Van Dorpe, L. Smeijers, I. Dewachter, D. Nuyens, K. Spittaels, C. Van den Haute, M. Mercken, D. Moechars, I. Laenen, C. Kuiperi, et al.
Prominent Cerebral Amyloid Angiopathy in Transgenic Mice Overexpressing the London Mutant of Human APP in Neurons
Am. J. Pathol., October 1, 2000; 157(4): 1283 - 1298.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Yamada, Y. Itoh, M. Shintaku, J. Kawamura, O. Jensson, L. Thorsteinsson, N. Suematsu, M. Matsushita, and E. Otomo
Immune Reactions Associated With Cerebral Amyloid Angiopathy
Stroke, July 1, 1996; 27(7): 1155 - 1162.
[Abstract] [Full Text]


Home page
ScienceHome page
D. Selkoe
Deciphering Alzheimer's disease: the amyloid precursor protein yields new clues
Science, June 1, 1990; 248(4959): 1058 - 1060.
[PDF]


Home page
ScienceHome page
W. Van Nostrand, A. Schmaier, J. Farrow, and D. Cunningham
Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein
Science, May 11, 1990; 248(4956): 745 - 748.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Society for Investigative Pathology.